Global Anti-PD-1 MAb Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
LPI (LP Information)' newest research report, the “Anti-PD-1 MAb Industry Forecast” looks at past sales and reviews total world Anti-PD-1 MAb sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti-PD-1 MAb sales for 2023 through 2029. With Anti-PD-1 MAb sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-PD-1 MAb industry.
This Insight Report provides a comprehensive analysis of the global Anti-PD-1 MAb landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-PD-1 MAb portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Anti-PD-1 MAb market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-PD-1 MAb and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-PD-1 MAb.
The global Anti-PD-1 MAb market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Anti-PD-1 MAb is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Anti-PD-1 MAb is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Anti-PD-1 MAb is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Anti-PD-1 MAb players cover Bristol Myers Squibb, Merck, Junshi Pharma, Innovent Biologics Inc, Hengrui Medicine and Beijing Beigene, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-PD-1 MAb market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Anti-PD-1 MAb market?
What factors are driving Anti-PD-1 MAb market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-PD-1 MAb market opportunities vary by end market size?
How does Anti-PD-1 MAb break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
LPI (LP Information)' newest research report, the “Anti-PD-1 MAb Industry Forecast” looks at past sales and reviews total world Anti-PD-1 MAb sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti-PD-1 MAb sales for 2023 through 2029. With Anti-PD-1 MAb sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-PD-1 MAb industry.
This Insight Report provides a comprehensive analysis of the global Anti-PD-1 MAb landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-PD-1 MAb portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Anti-PD-1 MAb market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-PD-1 MAb and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-PD-1 MAb.
The global Anti-PD-1 MAb market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Anti-PD-1 MAb is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Anti-PD-1 MAb is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Anti-PD-1 MAb is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Anti-PD-1 MAb players cover Bristol Myers Squibb, Merck, Junshi Pharma, Innovent Biologics Inc, Hengrui Medicine and Beijing Beigene, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-PD-1 MAb market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- 40mg
- 100mg
- 200mg
- Others
- Melanoma Patients
- Lung Cancer Patients
- Lymphoma Patients
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bristol Myers Squibb
- Merck
- Junshi Pharma
- Innovent Biologics Inc
- Hengrui Medicine
- Beijing Beigene
What is the 10-year outlook for the global Anti-PD-1 MAb market?
What factors are driving Anti-PD-1 MAb market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-PD-1 MAb market opportunities vary by end market size?
How does Anti-PD-1 MAb break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-PD-1 MAb Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Anti-PD-1 MAb by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Anti-PD-1 MAb by Country/Region, 2018, 2022 & 2029
2.2 Anti-PD-1 MAb Segment by Type
2.2.1 40mg
2.2.2 100mg
2.2.3 200mg
2.2.4 Others
2.3 Anti-PD-1 MAb Sales by Type
2.3.1 Global Anti-PD-1 MAb Sales Market Share by Type (2018-2023)
2.3.2 Global Anti-PD-1 MAb Revenue and Market Share by Type (2018-2023)
2.3.3 Global Anti-PD-1 MAb Sale Price by Type (2018-2023)
2.4 Anti-PD-1 MAb Segment by Application
2.4.1 Melanoma Patients
2.4.2 Lung Cancer Patients
2.4.3 Lymphoma Patients
2.4.4 Other
2.5 Anti-PD-1 MAb Sales by Application
2.5.1 Global Anti-PD-1 MAb Sale Market Share by Application (2018-2023)
2.5.2 Global Anti-PD-1 MAb Revenue and Market Share by Application (2018-2023)
2.5.3 Global Anti-PD-1 MAb Sale Price by Application (2018-2023)
3 GLOBAL ANTI-PD-1 MAB BY COMPANY
3.1 Global Anti-PD-1 MAb Breakdown Data by Company
3.1.1 Global Anti-PD-1 MAb Annual Sales by Company (2018-2023)
3.1.2 Global Anti-PD-1 MAb Sales Market Share by Company (2018-2023)
3.2 Global Anti-PD-1 MAb Annual Revenue by Company (2018-2023)
3.2.1 Global Anti-PD-1 MAb Revenue by Company (2018-2023)
3.2.2 Global Anti-PD-1 MAb Revenue Market Share by Company (2018-2023)
3.3 Global Anti-PD-1 MAb Sale Price by Company
3.4 Key Manufacturers Anti-PD-1 MAb Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-PD-1 MAb Product Location Distribution
3.4.2 Players Anti-PD-1 MAb Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ANTI-PD-1 MAB BY GEOGRAPHIC REGION
4.1 World Historic Anti-PD-1 MAb Market Size by Geographic Region (2018-2023)
4.1.1 Global Anti-PD-1 MAb Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Anti-PD-1 MAb Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Anti-PD-1 MAb Market Size by Country/Region (2018-2023)
4.2.1 Global Anti-PD-1 MAb Annual Sales by Country/Region (2018-2023)
4.2.2 Global Anti-PD-1 MAb Annual Revenue by Country/Region (2018-2023)
4.3 Americas Anti-PD-1 MAb Sales Growth
4.4 APAC Anti-PD-1 MAb Sales Growth
4.5 Europe Anti-PD-1 MAb Sales Growth
4.6 Middle East & Africa Anti-PD-1 MAb Sales Growth
5 AMERICAS
5.1 Americas Anti-PD-1 MAb Sales by Country
5.1.1 Americas Anti-PD-1 MAb Sales by Country (2018-2023)
5.1.2 Americas Anti-PD-1 MAb Revenue by Country (2018-2023)
5.2 Americas Anti-PD-1 MAb Sales by Type
5.3 Americas Anti-PD-1 MAb Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-PD-1 MAb Sales by Region
6.1.1 APAC Anti-PD-1 MAb Sales by Region (2018-2023)
6.1.2 APAC Anti-PD-1 MAb Revenue by Region (2018-2023)
6.2 APAC Anti-PD-1 MAb Sales by Type
6.3 APAC Anti-PD-1 MAb Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-PD-1 MAb by Country
7.1.1 Europe Anti-PD-1 MAb Sales by Country (2018-2023)
7.1.2 Europe Anti-PD-1 MAb Revenue by Country (2018-2023)
7.2 Europe Anti-PD-1 MAb Sales by Type
7.3 Europe Anti-PD-1 MAb Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-PD-1 MAb by Country
8.1.1 Middle East & Africa Anti-PD-1 MAb Sales by Country (2018-2023)
8.1.2 Middle East & Africa Anti-PD-1 MAb Revenue by Country (2018-2023)
8.2 Middle East & Africa Anti-PD-1 MAb Sales by Type
8.3 Middle East & Africa Anti-PD-1 MAb Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-PD-1 MAb
10.3 Manufacturing Process Analysis of Anti-PD-1 MAb
10.4 Industry Chain Structure of Anti-PD-1 MAb
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-PD-1 MAb Distributors
11.3 Anti-PD-1 MAb Customer
12 WORLD FORECAST REVIEW FOR ANTI-PD-1 MAB BY GEOGRAPHIC REGION
12.1 Global Anti-PD-1 MAb Market Size Forecast by Region
12.1.1 Global Anti-PD-1 MAb Forecast by Region (2024-2029)
12.1.2 Global Anti-PD-1 MAb Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anti-PD-1 MAb Forecast by Type
12.7 Global Anti-PD-1 MAb Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bristol Myers Squibb
13.1.1 Bristol Myers Squibb Company Information
13.1.2 Bristol Myers Squibb Anti-PD-1 MAb Product Portfolios and Specifications
13.1.3 Bristol Myers Squibb Anti-PD-1 MAb Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bristol Myers Squibb Main Business Overview
13.1.5 Bristol Myers Squibb Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Anti-PD-1 MAb Product Portfolios and Specifications
13.2.3 Merck Anti-PD-1 MAb Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Junshi Pharma
13.3.1 Junshi Pharma Company Information
13.3.2 Junshi Pharma Anti-PD-1 MAb Product Portfolios and Specifications
13.3.3 Junshi Pharma Anti-PD-1 MAb Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Junshi Pharma Main Business Overview
13.3.5 Junshi Pharma Latest Developments
13.4 Innovent Biologics Inc
13.4.1 Innovent Biologics Inc Company Information
13.4.2 Innovent Biologics Inc Anti-PD-1 MAb Product Portfolios and Specifications
13.4.3 Innovent Biologics Inc Anti-PD-1 MAb Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Innovent Biologics Inc Main Business Overview
13.4.5 Innovent Biologics Inc Latest Developments
13.5 Hengrui Medicine
13.5.1 Hengrui Medicine Company Information
13.5.2 Hengrui Medicine Anti-PD-1 MAb Product Portfolios and Specifications
13.5.3 Hengrui Medicine Anti-PD-1 MAb Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Hengrui Medicine Main Business Overview
13.5.5 Hengrui Medicine Latest Developments
13.6 Beijing Beigene
13.6.1 Beijing Beigene Company Information
13.6.2 Beijing Beigene Anti-PD-1 MAb Product Portfolios and Specifications
13.6.3 Beijing Beigene Anti-PD-1 MAb Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Beijing Beigene Main Business Overview
13.6.5 Beijing Beigene Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-PD-1 MAb Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Anti-PD-1 MAb by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Anti-PD-1 MAb by Country/Region, 2018, 2022 & 2029
2.2 Anti-PD-1 MAb Segment by Type
2.2.1 40mg
2.2.2 100mg
2.2.3 200mg
2.2.4 Others
2.3 Anti-PD-1 MAb Sales by Type
2.3.1 Global Anti-PD-1 MAb Sales Market Share by Type (2018-2023)
2.3.2 Global Anti-PD-1 MAb Revenue and Market Share by Type (2018-2023)
2.3.3 Global Anti-PD-1 MAb Sale Price by Type (2018-2023)
2.4 Anti-PD-1 MAb Segment by Application
2.4.1 Melanoma Patients
2.4.2 Lung Cancer Patients
2.4.3 Lymphoma Patients
2.4.4 Other
2.5 Anti-PD-1 MAb Sales by Application
2.5.1 Global Anti-PD-1 MAb Sale Market Share by Application (2018-2023)
2.5.2 Global Anti-PD-1 MAb Revenue and Market Share by Application (2018-2023)
2.5.3 Global Anti-PD-1 MAb Sale Price by Application (2018-2023)
3 GLOBAL ANTI-PD-1 MAB BY COMPANY
3.1 Global Anti-PD-1 MAb Breakdown Data by Company
3.1.1 Global Anti-PD-1 MAb Annual Sales by Company (2018-2023)
3.1.2 Global Anti-PD-1 MAb Sales Market Share by Company (2018-2023)
3.2 Global Anti-PD-1 MAb Annual Revenue by Company (2018-2023)
3.2.1 Global Anti-PD-1 MAb Revenue by Company (2018-2023)
3.2.2 Global Anti-PD-1 MAb Revenue Market Share by Company (2018-2023)
3.3 Global Anti-PD-1 MAb Sale Price by Company
3.4 Key Manufacturers Anti-PD-1 MAb Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-PD-1 MAb Product Location Distribution
3.4.2 Players Anti-PD-1 MAb Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR ANTI-PD-1 MAB BY GEOGRAPHIC REGION
4.1 World Historic Anti-PD-1 MAb Market Size by Geographic Region (2018-2023)
4.1.1 Global Anti-PD-1 MAb Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Anti-PD-1 MAb Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Anti-PD-1 MAb Market Size by Country/Region (2018-2023)
4.2.1 Global Anti-PD-1 MAb Annual Sales by Country/Region (2018-2023)
4.2.2 Global Anti-PD-1 MAb Annual Revenue by Country/Region (2018-2023)
4.3 Americas Anti-PD-1 MAb Sales Growth
4.4 APAC Anti-PD-1 MAb Sales Growth
4.5 Europe Anti-PD-1 MAb Sales Growth
4.6 Middle East & Africa Anti-PD-1 MAb Sales Growth
5 AMERICAS
5.1 Americas Anti-PD-1 MAb Sales by Country
5.1.1 Americas Anti-PD-1 MAb Sales by Country (2018-2023)
5.1.2 Americas Anti-PD-1 MAb Revenue by Country (2018-2023)
5.2 Americas Anti-PD-1 MAb Sales by Type
5.3 Americas Anti-PD-1 MAb Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-PD-1 MAb Sales by Region
6.1.1 APAC Anti-PD-1 MAb Sales by Region (2018-2023)
6.1.2 APAC Anti-PD-1 MAb Revenue by Region (2018-2023)
6.2 APAC Anti-PD-1 MAb Sales by Type
6.3 APAC Anti-PD-1 MAb Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-PD-1 MAb by Country
7.1.1 Europe Anti-PD-1 MAb Sales by Country (2018-2023)
7.1.2 Europe Anti-PD-1 MAb Revenue by Country (2018-2023)
7.2 Europe Anti-PD-1 MAb Sales by Type
7.3 Europe Anti-PD-1 MAb Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-PD-1 MAb by Country
8.1.1 Middle East & Africa Anti-PD-1 MAb Sales by Country (2018-2023)
8.1.2 Middle East & Africa Anti-PD-1 MAb Revenue by Country (2018-2023)
8.2 Middle East & Africa Anti-PD-1 MAb Sales by Type
8.3 Middle East & Africa Anti-PD-1 MAb Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-PD-1 MAb
10.3 Manufacturing Process Analysis of Anti-PD-1 MAb
10.4 Industry Chain Structure of Anti-PD-1 MAb
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-PD-1 MAb Distributors
11.3 Anti-PD-1 MAb Customer
12 WORLD FORECAST REVIEW FOR ANTI-PD-1 MAB BY GEOGRAPHIC REGION
12.1 Global Anti-PD-1 MAb Market Size Forecast by Region
12.1.1 Global Anti-PD-1 MAb Forecast by Region (2024-2029)
12.1.2 Global Anti-PD-1 MAb Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anti-PD-1 MAb Forecast by Type
12.7 Global Anti-PD-1 MAb Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Bristol Myers Squibb
13.1.1 Bristol Myers Squibb Company Information
13.1.2 Bristol Myers Squibb Anti-PD-1 MAb Product Portfolios and Specifications
13.1.3 Bristol Myers Squibb Anti-PD-1 MAb Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bristol Myers Squibb Main Business Overview
13.1.5 Bristol Myers Squibb Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Anti-PD-1 MAb Product Portfolios and Specifications
13.2.3 Merck Anti-PD-1 MAb Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Junshi Pharma
13.3.1 Junshi Pharma Company Information
13.3.2 Junshi Pharma Anti-PD-1 MAb Product Portfolios and Specifications
13.3.3 Junshi Pharma Anti-PD-1 MAb Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Junshi Pharma Main Business Overview
13.3.5 Junshi Pharma Latest Developments
13.4 Innovent Biologics Inc
13.4.1 Innovent Biologics Inc Company Information
13.4.2 Innovent Biologics Inc Anti-PD-1 MAb Product Portfolios and Specifications
13.4.3 Innovent Biologics Inc Anti-PD-1 MAb Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Innovent Biologics Inc Main Business Overview
13.4.5 Innovent Biologics Inc Latest Developments
13.5 Hengrui Medicine
13.5.1 Hengrui Medicine Company Information
13.5.2 Hengrui Medicine Anti-PD-1 MAb Product Portfolios and Specifications
13.5.3 Hengrui Medicine Anti-PD-1 MAb Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Hengrui Medicine Main Business Overview
13.5.5 Hengrui Medicine Latest Developments
13.6 Beijing Beigene
13.6.1 Beijing Beigene Company Information
13.6.2 Beijing Beigene Anti-PD-1 MAb Product Portfolios and Specifications
13.6.3 Beijing Beigene Anti-PD-1 MAb Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Beijing Beigene Main Business Overview
13.6.5 Beijing Beigene Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Anti-PD-1 MAb Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Anti-PD-1 MAb Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 40mg
Table 4. Major Players of 100mg
Table 5. Major Players of 200mg
Table 6. Major Players of Others
Table 7. Global Anti-PD-1 MAb Sales by Type (2018-2023) & (KG)
Table 8. Global Anti-PD-1 MAb Sales Market Share by Type (2018-2023)
Table 9. Global Anti-PD-1 MAb Revenue by Type (2018-2023) & ($ million)
Table 10. Global Anti-PD-1 MAb Revenue Market Share by Type (2018-2023)
Table 11. Global Anti-PD-1 MAb Sale Price by Type (2018-2023) & (USD/KG)
Table 12. Global Anti-PD-1 MAb Sales by Application (2018-2023) & (KG)
Table 13. Global Anti-PD-1 MAb Sales Market Share by Application (2018-2023)
Table 14. Global Anti-PD-1 MAb Revenue by Application (2018-2023)
Table 15. Global Anti-PD-1 MAb Revenue Market Share by Application (2018-2023)
Table 16. Global Anti-PD-1 MAb Sale Price by Application (2018-2023) & (USD/KG)
Table 17. Global Anti-PD-1 MAb Sales by Company (2018-2023) & (KG)
Table 18. Global Anti-PD-1 MAb Sales Market Share by Company (2018-2023)
Table 19. Global Anti-PD-1 MAb Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Anti-PD-1 MAb Revenue Market Share by Company (2018-2023)
Table 21. Global Anti-PD-1 MAb Sale Price by Company (2018-2023) & (USD/KG)
Table 22. Key Manufacturers Anti-PD-1 MAb Producing Area Distribution and Sales Area
Table 23. Players Anti-PD-1 MAb Products Offered
Table 24. Anti-PD-1 MAb Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Anti-PD-1 MAb Sales by Geographic Region (2018-2023) & (KG)
Table 28. Global Anti-PD-1 MAb Sales Market Share Geographic Region (2018-2023)
Table 29. Global Anti-PD-1 MAb Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Anti-PD-1 MAb Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Anti-PD-1 MAb Sales by Country/Region (2018-2023) & (KG)
Table 32. Global Anti-PD-1 MAb Sales Market Share by Country/Region (2018-2023)
Table 33. Global Anti-PD-1 MAb Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Anti-PD-1 MAb Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Anti-PD-1 MAb Sales by Country (2018-2023) & (KG)
Table 36. Americas Anti-PD-1 MAb Sales Market Share by Country (2018-2023)
Table 37. Americas Anti-PD-1 MAb Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Anti-PD-1 MAb Revenue Market Share by Country (2018-2023)
Table 39. Americas Anti-PD-1 MAb Sales by Type (2018-2023) & (KG)
Table 40. Americas Anti-PD-1 MAb Sales by Application (2018-2023) & (KG)
Table 41. APAC Anti-PD-1 MAb Sales by Region (2018-2023) & (KG)
Table 42. APAC Anti-PD-1 MAb Sales Market Share by Region (2018-2023)
Table 43. APAC Anti-PD-1 MAb Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Anti-PD-1 MAb Revenue Market Share by Region (2018-2023)
Table 45. APAC Anti-PD-1 MAb Sales by Type (2018-2023) & (KG)
Table 46. APAC Anti-PD-1 MAb Sales by Application (2018-2023) & (KG)
Table 47. Europe Anti-PD-1 MAb Sales by Country (2018-2023) & (KG)
Table 48. Europe Anti-PD-1 MAb Sales Market Share by Country (2018-2023)
Table 49. Europe Anti-PD-1 MAb Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Anti-PD-1 MAb Revenue Market Share by Country (2018-2023)
Table 51. Europe Anti-PD-1 MAb Sales by Type (2018-2023) & (KG)
Table 52. Europe Anti-PD-1 MAb Sales by Application (2018-2023) & (KG)
Table 53. Middle East & Africa Anti-PD-1 MAb Sales by Country (2018-2023) & (KG)
Table 54. Middle East & Africa Anti-PD-1 MAb Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Anti-PD-1 MAb Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Anti-PD-1 MAb Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Anti-PD-1 MAb Sales by Type (2018-2023) & (KG)
Table 58. Middle East & Africa Anti-PD-1 MAb Sales by Application (2018-2023) & (KG)
Table 59. Key Market Drivers & Growth Opportunities of Anti-PD-1 MAb
Table 60. Key Market Challenges & Risks of Anti-PD-1 MAb
Table 61. Key Industry Trends of Anti-PD-1 MAb
Table 62. Anti-PD-1 MAb Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Anti-PD-1 MAb Distributors List
Table 65. Anti-PD-1 MAb Customer List
Table 66. Global Anti-PD-1 MAb Sales Forecast by Region (2024-2029) & (KG)
Table 67. Global Anti-PD-1 MAb Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Anti-PD-1 MAb Sales Forecast by Country (2024-2029) & (KG)
Table 69. Americas Anti-PD-1 MAb Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Anti-PD-1 MAb Sales Forecast by Region (2024-2029) & (KG)
Table 71. APAC Anti-PD-1 MAb Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Anti-PD-1 MAb Sales Forecast by Country (2024-2029) & (KG)
Table 73. Europe Anti-PD-1 MAb Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Anti-PD-1 MAb Sales Forecast by Country (2024-2029) & (KG)
Table 75. Middle East & Africa Anti-PD-1 MAb Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Anti-PD-1 MAb Sales Forecast by Type (2024-2029) & (KG)
Table 77. Global Anti-PD-1 MAb Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Anti-PD-1 MAb Sales Forecast by Application (2024-2029) & (KG)
Table 79. Global Anti-PD-1 MAb Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Bristol Myers Squibb Basic Information, Anti-PD-1 MAb Manufacturing Base, Sales Area and Its Competitors
Table 81. Bristol Myers Squibb Anti-PD-1 MAb Product Portfolios and Specifications
Table 82. Bristol Myers Squibb Anti-PD-1 MAb Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 83. Bristol Myers Squibb Main Business
Table 84. Bristol Myers Squibb Latest Developments
Table 85. Merck Basic Information, Anti-PD-1 MAb Manufacturing Base, Sales Area and Its Competitors
Table 86. Merck Anti-PD-1 MAb Product Portfolios and Specifications
Table 87. Merck Anti-PD-1 MAb Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 88. Merck Main Business
Table 89. Merck Latest Developments
Table 90. Junshi Pharma Basic Information, Anti-PD-1 MAb Manufacturing Base, Sales Area and Its Competitors
Table 91. Junshi Pharma Anti-PD-1 MAb Product Portfolios and Specifications
Table 92. Junshi Pharma Anti-PD-1 MAb Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 93. Junshi Pharma Main Business
Table 94. Junshi Pharma Latest Developments
Table 95. Innovent Biologics Inc Basic Information, Anti-PD-1 MAb Manufacturing Base, Sales Area and Its Competitors
Table 96. Innovent Biologics Inc Anti-PD-1 MAb Product Portfolios and Specifications
Table 97. Innovent Biologics Inc Anti-PD-1 MAb Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 98. Innovent Biologics Inc Main Business
Table 99. Innovent Biologics Inc Latest Developments
Table 100. Hengrui Medicine Basic Information, Anti-PD-1 MAb Manufacturing Base, Sales Area and Its Competitors
Table 101. Hengrui Medicine Anti-PD-1 MAb Product Portfolios and Specifications
Table 102. Hengrui Medicine Anti-PD-1 MAb Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 103. Hengrui Medicine Main Business
Table 104. Hengrui Medicine Latest Developments
Table 105. Beijing Beigene Basic Information, Anti-PD-1 MAb Manufacturing Base, Sales Area and Its Competitors
Table 106. Beijing Beigene Anti-PD-1 MAb Product Portfolios and Specifications
Table 107. Beijing Beigene Anti-PD-1 MAb Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 108. Beijing Beigene Main Business
Table 109. Beijing Beigene Latest Developments
Table 1. Anti-PD-1 MAb Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Anti-PD-1 MAb Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of 40mg
Table 4. Major Players of 100mg
Table 5. Major Players of 200mg
Table 6. Major Players of Others
Table 7. Global Anti-PD-1 MAb Sales by Type (2018-2023) & (KG)
Table 8. Global Anti-PD-1 MAb Sales Market Share by Type (2018-2023)
Table 9. Global Anti-PD-1 MAb Revenue by Type (2018-2023) & ($ million)
Table 10. Global Anti-PD-1 MAb Revenue Market Share by Type (2018-2023)
Table 11. Global Anti-PD-1 MAb Sale Price by Type (2018-2023) & (USD/KG)
Table 12. Global Anti-PD-1 MAb Sales by Application (2018-2023) & (KG)
Table 13. Global Anti-PD-1 MAb Sales Market Share by Application (2018-2023)
Table 14. Global Anti-PD-1 MAb Revenue by Application (2018-2023)
Table 15. Global Anti-PD-1 MAb Revenue Market Share by Application (2018-2023)
Table 16. Global Anti-PD-1 MAb Sale Price by Application (2018-2023) & (USD/KG)
Table 17. Global Anti-PD-1 MAb Sales by Company (2018-2023) & (KG)
Table 18. Global Anti-PD-1 MAb Sales Market Share by Company (2018-2023)
Table 19. Global Anti-PD-1 MAb Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Anti-PD-1 MAb Revenue Market Share by Company (2018-2023)
Table 21. Global Anti-PD-1 MAb Sale Price by Company (2018-2023) & (USD/KG)
Table 22. Key Manufacturers Anti-PD-1 MAb Producing Area Distribution and Sales Area
Table 23. Players Anti-PD-1 MAb Products Offered
Table 24. Anti-PD-1 MAb Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Anti-PD-1 MAb Sales by Geographic Region (2018-2023) & (KG)
Table 28. Global Anti-PD-1 MAb Sales Market Share Geographic Region (2018-2023)
Table 29. Global Anti-PD-1 MAb Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Anti-PD-1 MAb Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Anti-PD-1 MAb Sales by Country/Region (2018-2023) & (KG)
Table 32. Global Anti-PD-1 MAb Sales Market Share by Country/Region (2018-2023)
Table 33. Global Anti-PD-1 MAb Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Anti-PD-1 MAb Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Anti-PD-1 MAb Sales by Country (2018-2023) & (KG)
Table 36. Americas Anti-PD-1 MAb Sales Market Share by Country (2018-2023)
Table 37. Americas Anti-PD-1 MAb Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Anti-PD-1 MAb Revenue Market Share by Country (2018-2023)
Table 39. Americas Anti-PD-1 MAb Sales by Type (2018-2023) & (KG)
Table 40. Americas Anti-PD-1 MAb Sales by Application (2018-2023) & (KG)
Table 41. APAC Anti-PD-1 MAb Sales by Region (2018-2023) & (KG)
Table 42. APAC Anti-PD-1 MAb Sales Market Share by Region (2018-2023)
Table 43. APAC Anti-PD-1 MAb Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Anti-PD-1 MAb Revenue Market Share by Region (2018-2023)
Table 45. APAC Anti-PD-1 MAb Sales by Type (2018-2023) & (KG)
Table 46. APAC Anti-PD-1 MAb Sales by Application (2018-2023) & (KG)
Table 47. Europe Anti-PD-1 MAb Sales by Country (2018-2023) & (KG)
Table 48. Europe Anti-PD-1 MAb Sales Market Share by Country (2018-2023)
Table 49. Europe Anti-PD-1 MAb Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Anti-PD-1 MAb Revenue Market Share by Country (2018-2023)
Table 51. Europe Anti-PD-1 MAb Sales by Type (2018-2023) & (KG)
Table 52. Europe Anti-PD-1 MAb Sales by Application (2018-2023) & (KG)
Table 53. Middle East & Africa Anti-PD-1 MAb Sales by Country (2018-2023) & (KG)
Table 54. Middle East & Africa Anti-PD-1 MAb Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Anti-PD-1 MAb Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Anti-PD-1 MAb Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Anti-PD-1 MAb Sales by Type (2018-2023) & (KG)
Table 58. Middle East & Africa Anti-PD-1 MAb Sales by Application (2018-2023) & (KG)
Table 59. Key Market Drivers & Growth Opportunities of Anti-PD-1 MAb
Table 60. Key Market Challenges & Risks of Anti-PD-1 MAb
Table 61. Key Industry Trends of Anti-PD-1 MAb
Table 62. Anti-PD-1 MAb Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Anti-PD-1 MAb Distributors List
Table 65. Anti-PD-1 MAb Customer List
Table 66. Global Anti-PD-1 MAb Sales Forecast by Region (2024-2029) & (KG)
Table 67. Global Anti-PD-1 MAb Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Anti-PD-1 MAb Sales Forecast by Country (2024-2029) & (KG)
Table 69. Americas Anti-PD-1 MAb Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Anti-PD-1 MAb Sales Forecast by Region (2024-2029) & (KG)
Table 71. APAC Anti-PD-1 MAb Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Anti-PD-1 MAb Sales Forecast by Country (2024-2029) & (KG)
Table 73. Europe Anti-PD-1 MAb Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Anti-PD-1 MAb Sales Forecast by Country (2024-2029) & (KG)
Table 75. Middle East & Africa Anti-PD-1 MAb Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Anti-PD-1 MAb Sales Forecast by Type (2024-2029) & (KG)
Table 77. Global Anti-PD-1 MAb Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Anti-PD-1 MAb Sales Forecast by Application (2024-2029) & (KG)
Table 79. Global Anti-PD-1 MAb Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Bristol Myers Squibb Basic Information, Anti-PD-1 MAb Manufacturing Base, Sales Area and Its Competitors
Table 81. Bristol Myers Squibb Anti-PD-1 MAb Product Portfolios and Specifications
Table 82. Bristol Myers Squibb Anti-PD-1 MAb Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 83. Bristol Myers Squibb Main Business
Table 84. Bristol Myers Squibb Latest Developments
Table 85. Merck Basic Information, Anti-PD-1 MAb Manufacturing Base, Sales Area and Its Competitors
Table 86. Merck Anti-PD-1 MAb Product Portfolios and Specifications
Table 87. Merck Anti-PD-1 MAb Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 88. Merck Main Business
Table 89. Merck Latest Developments
Table 90. Junshi Pharma Basic Information, Anti-PD-1 MAb Manufacturing Base, Sales Area and Its Competitors
Table 91. Junshi Pharma Anti-PD-1 MAb Product Portfolios and Specifications
Table 92. Junshi Pharma Anti-PD-1 MAb Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 93. Junshi Pharma Main Business
Table 94. Junshi Pharma Latest Developments
Table 95. Innovent Biologics Inc Basic Information, Anti-PD-1 MAb Manufacturing Base, Sales Area and Its Competitors
Table 96. Innovent Biologics Inc Anti-PD-1 MAb Product Portfolios and Specifications
Table 97. Innovent Biologics Inc Anti-PD-1 MAb Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 98. Innovent Biologics Inc Main Business
Table 99. Innovent Biologics Inc Latest Developments
Table 100. Hengrui Medicine Basic Information, Anti-PD-1 MAb Manufacturing Base, Sales Area and Its Competitors
Table 101. Hengrui Medicine Anti-PD-1 MAb Product Portfolios and Specifications
Table 102. Hengrui Medicine Anti-PD-1 MAb Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 103. Hengrui Medicine Main Business
Table 104. Hengrui Medicine Latest Developments
Table 105. Beijing Beigene Basic Information, Anti-PD-1 MAb Manufacturing Base, Sales Area and Its Competitors
Table 106. Beijing Beigene Anti-PD-1 MAb Product Portfolios and Specifications
Table 107. Beijing Beigene Anti-PD-1 MAb Sales (KG), Revenue ($ Million), Price (USD/KG) and Gross Margin (2018-2023)
Table 108. Beijing Beigene Main Business
Table 109. Beijing Beigene Latest Developments
LIST OF FIGURES
Figure 1. Picture of Anti-PD-1 MAb
Figure 2. Anti-PD-1 MAb Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-PD-1 MAb Sales Growth Rate 2018-2029 (KG)
Figure 7. Global Anti-PD-1 MAb Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Anti-PD-1 MAb Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 40mg
Figure 10. Product Picture of 100mg
Figure 11. Product Picture of 200mg
Figure 12. Product Picture of Others
Figure 13. Global Anti-PD-1 MAb Sales Market Share by Type in 2022
Figure 14. Global Anti-PD-1 MAb Revenue Market Share by Type (2018-2023)
Figure 15. Anti-PD-1 MAb Consumed in Melanoma Patients
Figure 16. Global Anti-PD-1 MAb Market: Melanoma Patients (2018-2023) & (KG)
Figure 17. Anti-PD-1 MAb Consumed in Lung Cancer Patients
Figure 18. Global Anti-PD-1 MAb Market: Lung Cancer Patients (2018-2023) & (KG)
Figure 19. Anti-PD-1 MAb Consumed in Lymphoma Patients
Figure 20. Global Anti-PD-1 MAb Market: Lymphoma Patients (2018-2023) & (KG)
Figure 21. Anti-PD-1 MAb Consumed in Other
Figure 22. Global Anti-PD-1 MAb Market: Other (2018-2023) & (KG)
Figure 23. Global Anti-PD-1 MAb Sales Market Share by Application (2022)
Figure 24. Global Anti-PD-1 MAb Revenue Market Share by Application in 2022
Figure 25. Anti-PD-1 MAb Sales Market by Company in 2022 (KG)
Figure 26. Global Anti-PD-1 MAb Sales Market Share by Company in 2022
Figure 27. Anti-PD-1 MAb Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Anti-PD-1 MAb Revenue Market Share by Company in 2022
Figure 29. Global Anti-PD-1 MAb Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Anti-PD-1 MAb Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Anti-PD-1 MAb Sales 2018-2023 (KG)
Figure 32. Americas Anti-PD-1 MAb Revenue 2018-2023 ($ Millions)
Figure 33. APAC Anti-PD-1 MAb Sales 2018-2023 (KG)
Figure 34. APAC Anti-PD-1 MAb Revenue 2018-2023 ($ Millions)
Figure 35. Europe Anti-PD-1 MAb Sales 2018-2023 (KG)
Figure 36. Europe Anti-PD-1 MAb Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Anti-PD-1 MAb Sales 2018-2023 (KG)
Figure 38. Middle East & Africa Anti-PD-1 MAb Revenue 2018-2023 ($ Millions)
Figure 39. Americas Anti-PD-1 MAb Sales Market Share by Country in 2022
Figure 40. Americas Anti-PD-1 MAb Revenue Market Share by Country in 2022
Figure 41. Americas Anti-PD-1 MAb Sales Market Share by Type (2018-2023)
Figure 42. Americas Anti-PD-1 MAb Sales Market Share by Application (2018-2023)
Figure 43. United States Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Anti-PD-1 MAb Sales Market Share by Region in 2022
Figure 48. APAC Anti-PD-1 MAb Revenue Market Share by Regions in 2022
Figure 49. APAC Anti-PD-1 MAb Sales Market Share by Type (2018-2023)
Figure 50. APAC Anti-PD-1 MAb Sales Market Share by Application (2018-2023)
Figure 51. China Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Anti-PD-1 MAb Sales Market Share by Country in 2022
Figure 59. Europe Anti-PD-1 MAb Revenue Market Share by Country in 2022
Figure 60. Europe Anti-PD-1 MAb Sales Market Share by Type (2018-2023)
Figure 61. Europe Anti-PD-1 MAb Sales Market Share by Application (2018-2023)
Figure 62. Germany Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Anti-PD-1 MAb Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Anti-PD-1 MAb Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Anti-PD-1 MAb Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Anti-PD-1 MAb Sales Market Share by Application (2018-2023)
Figure 71. Egypt Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Anti-PD-1 MAb in 2022
Figure 77. Manufacturing Process Analysis of Anti-PD-1 MAb
Figure 78. Industry Chain Structure of Anti-PD-1 MAb
Figure 79. Channels of Distribution
Figure 80. Global Anti-PD-1 MAb Sales Market Forecast by Region (2024-2029)
Figure 81. Global Anti-PD-1 MAb Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Anti-PD-1 MAb Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Anti-PD-1 MAb Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Anti-PD-1 MAb Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Anti-PD-1 MAb Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Anti-PD-1 MAb
Figure 2. Anti-PD-1 MAb Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-PD-1 MAb Sales Growth Rate 2018-2029 (KG)
Figure 7. Global Anti-PD-1 MAb Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Anti-PD-1 MAb Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of 40mg
Figure 10. Product Picture of 100mg
Figure 11. Product Picture of 200mg
Figure 12. Product Picture of Others
Figure 13. Global Anti-PD-1 MAb Sales Market Share by Type in 2022
Figure 14. Global Anti-PD-1 MAb Revenue Market Share by Type (2018-2023)
Figure 15. Anti-PD-1 MAb Consumed in Melanoma Patients
Figure 16. Global Anti-PD-1 MAb Market: Melanoma Patients (2018-2023) & (KG)
Figure 17. Anti-PD-1 MAb Consumed in Lung Cancer Patients
Figure 18. Global Anti-PD-1 MAb Market: Lung Cancer Patients (2018-2023) & (KG)
Figure 19. Anti-PD-1 MAb Consumed in Lymphoma Patients
Figure 20. Global Anti-PD-1 MAb Market: Lymphoma Patients (2018-2023) & (KG)
Figure 21. Anti-PD-1 MAb Consumed in Other
Figure 22. Global Anti-PD-1 MAb Market: Other (2018-2023) & (KG)
Figure 23. Global Anti-PD-1 MAb Sales Market Share by Application (2022)
Figure 24. Global Anti-PD-1 MAb Revenue Market Share by Application in 2022
Figure 25. Anti-PD-1 MAb Sales Market by Company in 2022 (KG)
Figure 26. Global Anti-PD-1 MAb Sales Market Share by Company in 2022
Figure 27. Anti-PD-1 MAb Revenue Market by Company in 2022 ($ Million)
Figure 28. Global Anti-PD-1 MAb Revenue Market Share by Company in 2022
Figure 29. Global Anti-PD-1 MAb Sales Market Share by Geographic Region (2018-2023)
Figure 30. Global Anti-PD-1 MAb Revenue Market Share by Geographic Region in 2022
Figure 31. Americas Anti-PD-1 MAb Sales 2018-2023 (KG)
Figure 32. Americas Anti-PD-1 MAb Revenue 2018-2023 ($ Millions)
Figure 33. APAC Anti-PD-1 MAb Sales 2018-2023 (KG)
Figure 34. APAC Anti-PD-1 MAb Revenue 2018-2023 ($ Millions)
Figure 35. Europe Anti-PD-1 MAb Sales 2018-2023 (KG)
Figure 36. Europe Anti-PD-1 MAb Revenue 2018-2023 ($ Millions)
Figure 37. Middle East & Africa Anti-PD-1 MAb Sales 2018-2023 (KG)
Figure 38. Middle East & Africa Anti-PD-1 MAb Revenue 2018-2023 ($ Millions)
Figure 39. Americas Anti-PD-1 MAb Sales Market Share by Country in 2022
Figure 40. Americas Anti-PD-1 MAb Revenue Market Share by Country in 2022
Figure 41. Americas Anti-PD-1 MAb Sales Market Share by Type (2018-2023)
Figure 42. Americas Anti-PD-1 MAb Sales Market Share by Application (2018-2023)
Figure 43. United States Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 44. Canada Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 45. Mexico Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 46. Brazil Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 47. APAC Anti-PD-1 MAb Sales Market Share by Region in 2022
Figure 48. APAC Anti-PD-1 MAb Revenue Market Share by Regions in 2022
Figure 49. APAC Anti-PD-1 MAb Sales Market Share by Type (2018-2023)
Figure 50. APAC Anti-PD-1 MAb Sales Market Share by Application (2018-2023)
Figure 51. China Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 52. Japan Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 53. South Korea Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 54. Southeast Asia Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 55. India Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 56. Australia Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 57. China Taiwan Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 58. Europe Anti-PD-1 MAb Sales Market Share by Country in 2022
Figure 59. Europe Anti-PD-1 MAb Revenue Market Share by Country in 2022
Figure 60. Europe Anti-PD-1 MAb Sales Market Share by Type (2018-2023)
Figure 61. Europe Anti-PD-1 MAb Sales Market Share by Application (2018-2023)
Figure 62. Germany Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 63. France Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 64. UK Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 65. Italy Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 66. Russia Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 67. Middle East & Africa Anti-PD-1 MAb Sales Market Share by Country in 2022
Figure 68. Middle East & Africa Anti-PD-1 MAb Revenue Market Share by Country in 2022
Figure 69. Middle East & Africa Anti-PD-1 MAb Sales Market Share by Type (2018-2023)
Figure 70. Middle East & Africa Anti-PD-1 MAb Sales Market Share by Application (2018-2023)
Figure 71. Egypt Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 72. South Africa Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 73. Israel Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 74. Turkey Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 75. GCC Country Anti-PD-1 MAb Revenue Growth 2018-2023 ($ Millions)
Figure 76. Manufacturing Cost Structure Analysis of Anti-PD-1 MAb in 2022
Figure 77. Manufacturing Process Analysis of Anti-PD-1 MAb
Figure 78. Industry Chain Structure of Anti-PD-1 MAb
Figure 79. Channels of Distribution
Figure 80. Global Anti-PD-1 MAb Sales Market Forecast by Region (2024-2029)
Figure 81. Global Anti-PD-1 MAb Revenue Market Share Forecast by Region (2024-2029)
Figure 82. Global Anti-PD-1 MAb Sales Market Share Forecast by Type (2024-2029)
Figure 83. Global Anti-PD-1 MAb Revenue Market Share Forecast by Type (2024-2029)
Figure 84. Global Anti-PD-1 MAb Sales Market Share Forecast by Application (2024-2029)
Figure 85. Global Anti-PD-1 MAb Revenue Market Share Forecast by Application (2024-2029)
